Mastocytosis: mediator-related signs and symptoms

International Archives of Allergy and Immunology
Mariana Castells, K Frank Austen

Abstract

Patients with systemic mastocytosis present symptoms related to the tissue response to the release of mediators from mast cells and to the local mast cell burden. Such patients often have a history of chronic and acute mediator-related symptoms. Most patients have indolent disease with a good prognosis and a normal life span. Symptoms can include pruritus, flushing, syncope, gastric distress, nausea and vomiting, diarrhea, bone pain and neuropsychiatric symptoms, most of which are controlled by medication. Because there is no current cure for mastocytosis, successful therapeutic interventions rely on the recognition of mediator-related symptoms and their treatment, and established intervention approaches for the relatively uncommon leukemic concomitants. Efforts to link a particular mast cell-derived mediator to some aspect of the symptom complex depend on the known actions of the mediator and the efficacy of target-based interventions.

Citations

Nov 25, 2006·International Urogynecology Journal and Pelvic Floor Dysfunction·Ted M Roth
Feb 15, 2013·Journal of Anesthesia·Norma J Klein, Shad Misseldine
Jan 25, 2003·Current Allergy and Asthma Reports·Mariana C CastellsAlbert L Sheffer
Dec 19, 2003·Current Allergy and Asthma Reports·Ali A Siddiqui, Philip B Miner
Dec 6, 2012·Current Allergy and Asthma Reports·Juan-Carlos CardetMatthew J Hamilton
May 10, 2005·Immunology and Allergy Clinics of North America·Sachin Baxi, Chitra Dinakar
Dec 5, 2003·Leukemia Research·A PardananiA Tefferi
Feb 8, 2008·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·Mary C TobinAli Keshavarzian
Mar 25, 2011·The New England Journal of Medicine·Mandakolathur R MuraliRobert P Hasserjian
Nov 23, 2007·The Cancer Journal·Animesh Pardanani, Srdan Verstovsek
Mar 19, 2005·Cephalalgia : an International Journal of Headache·S Ashina, M Ashina
Mar 1, 2005·Journal of Clinical Pathology·A S JanssensA P Oranje
Oct 5, 2006·International Archives of Allergy and Immunology·Dimitris KalogeromitrosTheoharis C Theoharides
Jul 4, 2012·BMC Pediatrics·Asimenia AngelidouTheoharis C Theoharides
Jun 18, 2009·Seminars in Immunopathology·Stephan C Bischoff
Nov 28, 2012·Wiener klinische Wochenschrift·Peter ValentKarin Hartmann
Sep 9, 2010·Medizinische Klinik·Jürgen HomannGerhard J Molderings
Dec 29, 2004·Leukemia & Lymphoma·Peter ValentDean D Metcalfe
Apr 22, 2014·Immunology and Allergy Clinics of North America·Daniela S MouraOlivier Hermine
Feb 26, 2014·The Journal of Allergy and Clinical Immunology. in Practice·Patrizia BonadonnaGiovanni Passalacqua
Nov 3, 2012·Hematology/oncology Clinics of North America·Stephen J Fuller
Jun 15, 2011·Clinical Neurology and Neurosurgery·Jonathan H SmithF Michael Cutrer
May 31, 2011·The Journal of Allergy and Clinical Immunology·Matthew J HamiltonNorton J Greenberger
Jan 13, 2009·The Journal of Allergy and Clinical Immunology·Patrizia BonadonnaRoberta Zanotti
Aug 26, 2006·Immunology and Allergy Clinics of North America·Peter Valent
Aug 26, 2006·Immunology and Allergy Clinics of North America·Todd M WilsonJamie Robyn
Dec 20, 2008·Clinical and Experimental Dermatology·T C TheoharidesD Kalogeromitros
Aug 22, 2003·British Journal of Haematology·Peter ValentDean D Metcalfe
Jul 30, 2008·Liver International : Official Journal of the International Association for the Study of the Liver·Kirsten AlfterGerhard J Molderings
Feb 12, 2009·Paediatric Anaesthesia·Nargis AhmadAdrian R Lloyd-Thomas
May 14, 2011·Journal of the European Academy of Dermatology and Venereology : JEADV·V BrazzelliG Borroni
Apr 12, 2016·Translational Research : the Journal of Laboratory and Clinical Medicine·Sophie Georgin-LavialleOlivier Hermine
Sep 19, 2015·Clinical Lymphoma, Myeloma & Leukemia·Douglas TremblayJohn Mascarenhas
Oct 17, 2003·Hematology/oncology Clinics of North America·Peter ValentDean D Metcalfe
May 4, 2004·Immunology and Allergy Clinics of North America·Knut Brockow
Apr 4, 2015·Alcoholism, Clinical and Experimental Research·Carmen BeceiroArturo Gonzalez-Quintela
Sep 21, 2013·Expert Opinion on Pharmacotherapy·Juan Carlos CardetMin Jung Lee
Aug 7, 2013·Brain, Behavior, and Immunity·Sophie Georgin-LavialleOlivier Hermine
Jul 9, 2008·Trends in Pharmacological Sciences·Theoharis C TheoharidesDimitris Kalogeromitros

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.